Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer

被引：0
|
作者：
Hiroshi Okamoto
Yusuke Taniyama
Tadashi Sakurai
Takahiro Heishi
Jin Teshima
Chiaki Sato
Shota Maruyama
Ken Ito
Yu Onodera
Takuro Konno-Kumagai
Hirotaka Ishida
Takashi Kamei
机构：
[1] Tohoku University,Department of Gastroenterological Surgery, Graduate School of Medicine
[2] Tohoku University,Department of Community Medical Supports, Tohoku Medical Megabank Organization
[3] Iwate Prefectural Central Hospital,Department of Surgery
来源：
Esophagus | 2018年 / 15卷
关键词：
Esophageal squamous cell carcinoma; Chemoradiotherapy; Docetaxel; Cisplatin; 5-Fluorouracil;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：281 / 285
页数：4
相关论文
共 50 条
  • [1] Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer
    Okamoto, Hiroshi
    Taniyama, Yusuke
    Sakurai, Tadashi
    Heishi, Takahiro
    Teshima, Jin
    Sato, Chiaki
    Maruyama, Shota
    Ito, Ken
    Onodera, Yu
    Konno-Kumagai, Takuro
    Ishida, Hirotaka
    Kamei, Takashi
    ESOPHAGUS, 2018, 15 (04) : 281 - 285
  • [2] A phase II trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer (KDOG 0501-P2).
    Higuchi, Katsuhiko
    Komori, Shouko
    Tanabe, Satoshi
    Katada, Chikatoshi
    Azuma, Mizutomo
    Ishiyama, Hiromichi
    Sasaki, Tohru
    Ishido, Kenji
    Katada, Natsuya
    Hayakawa, Kazushige
    Koizumi, Wasaburo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Definitive Chemoradiation Therapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-R) in Advanced Esophageal Cancer: A Phase 2 Trial (KDOG 0501-P2)
    Higuchi, Katsuhiko
    Komori, Shouko
    Tanabe, Satoshi
    Katada, Chikatoshi
    Azuma, Mizutomo
    Ishiyama, Hiromichi
    Sasaki, Tohru
    Ishido, Kenji
    Katada, Natsuya
    Hayakawa, Kazushige
    Koizumi, Wasaburo
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (04): : 872 - 879
  • [4] A phase I trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma: Kitasato digestive disease & oncology group trial (KDOG 0501)
    Higuchi, Katsuhiko
    Koizumi, Wasaburo
    Tanabe, Satoshi
    Sasaki, Tohru
    Katada, Chikatoshi
    Ishiyama, Hiromichi
    Hayakawa, Kazushige
    RADIOTHERAPY AND ONCOLOGY, 2008, 87 (03) : 398 - 404
  • [5] Four cases of definitive chemoradiotherapy with docetaxel/cisplatin/fluorouracil for advanced cervical esophageal cancer
    Watanabe, Akinori
    Katada, Chikatoshi
    Furue, Yasuaki
    Wada, Takuya
    Ishido, Kenji
    Tanabe, Satoshi
    Koizumi, Wasaburo
    ANNALS OF ONCOLOGY, 2021, 32 : S329 - S329
  • [6] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
    Emi, Manabu
    Hihara, Jun
    Hamai, Yoichi
    Aoki, Yoshiro
    Okada, Morihito
    Kenjo, Masahiro
    Murakami, Yuji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1499 - 1505
  • [7] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
    Manabu Emi
    Jun Hihara
    Yoichi Hamai
    Yoshiro Aoki
    Morihito Okada
    Masahiro Kenjo
    Yuji Murakami
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1499 - 1505
  • [8] Induction chemoradiotherapy including docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal cancer
    Hashimoto, Masashi
    Shirakawa, Yasuhiro
    Maeda, Naoaki
    Tanabe, Shunsuke
    Noma, Kazuhiro
    Sakurama, Kazufumi
    Katsui, Kuniaki
    Nishizaki, Masahiko
    Fujiwara, Toshiyoshi
    ESOPHAGUS, 2020, 17 (02) : 127 - 134
  • [9] Induction chemoradiotherapy including docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal cancer
    Masashi Hashimoto
    Yasuhiro Shirakawa
    Naoaki Maeda
    Shunsuke Tanabe
    Kazuhiro Noma
    Kazufumi Sakurama
    Kuniaki Katsui
    Masahiko Nishizaki
    Toshiyoshi Fujiwara
    Esophagus, 2020, 17 : 127 - 134
  • [10] Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil
    Tamaki, Yukihisa
    Hieda, Yoko
    Nakajima, Masanobu
    Kitajima, Kazuhiro
    Yoshida, Rika
    Yoshizako, Takeshi
    Ue, Atsushi
    Tokudo, Mutsumi
    Hirahara, Noriyuki
    Moriyama, Ichiro
    Kato, Hiroyuki
    Inomata, Taisuke
    JOURNAL OF CANCER, 2018, 9 (16): : 2765 - 2772
12345